EWTX
Edgewise Therapeutics, Inc.Company with tickers: EWTX
CIK
1710072
CUSIP
28036F105
Shares Outstanding
107,593,006
13F Activity (30d)
133 filings
132 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-05 | Donovan Joanne M. |
CMO | Convert | 50,000 |
| 2026-05-05 | Donovan Joanne M. |
CMO | Sell | 50,000 |
| 2026-05-05 | Donovan Joanne M. |
CMO | Convert | 50,000 |
| 2026-05-04 | Donovan Joanne M. |
CMO | Sell | 5,230 |
| 2026-04-01 | Donovan Joanne M. |
CMO | Convert | 28,662 |
| 2026-04-01 | Fox Jonathan C |
Director | Award | 339 |
| 2026-04-01 | Donovan Joanne M. |
CMO | Sell | 28,662 |
| 2026-04-01 | Donovan Joanne M. |
CMO | Convert | 28,662 |
| 2026-03-31 | Donovan Joanne M. |
CMO | Sell | 21,338 |
| 2026-03-31 | Donovan Joanne M. |
CMO | Convert | 21,338 |
| 2026-03-31 | Donovan Joanne M. |
CMO | Convert | 21,338 |
| 2026-03-27 | Donovan Joanne M. |
CMO | Sell | 6,735 |
| 2026-03-27 | Donovan Joanne M. |
CMO | Sell | 9,623 |
| 2026-01-21 | Edris Badreddin |
Director | Sell | 66,477 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 17,236 |
| 2026-01-21 | Edris Badreddin |
Director | Sell | 17,236 |
| 2026-01-21 | Edris Badreddin |
Director | Sell | 10,463 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 17,236 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 13,690 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 66,477 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 13,690 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 10,463 |
| 2026-01-21 | Edris Badreddin |
Director | Sell | 13,690 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 10,463 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 7,605 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 66,477 |
| 2026-01-21 | Edris Badreddin |
Director | Convert | 7,605 |
| 2026-01-21 | Edris Badreddin |
Director | Sell | 7,605 |
| 2026-01-02 | Fox Jonathan C |
Director | Award | 473 |
| 2025-11-19 | Martin Christopher Nathan |
Director | Other | 0 |
| 2025-11-19 | Martin Christopher Nathan |
Director | Award | 45,150 |
| 2025-11-12 | Russell Alan J |
Director, Chief Scientific Officer | Sell | 100,000 |
| 2025-11-12 | Russell Alan J |
Director, Chief Scientific Officer | Convert | 100,000 |
| 2025-11-12 | Russell Alan J |
Director, Chief Scientific Officer | Convert | 100,000 |
| 2025-11-11 | Fox Jonathan C |
Director | Buy | 10,700 |
| 2025-11-10 | Nofi Michael |
Chief Financial Officer | Other | 0 |
| 2025-11-10 | Nofi Michael |
Chief Financial Officer | Award | 43,750 |
| 2025-11-10 | Nofi Michael |
Chief Financial Officer | Award | 262,500 |
| 2025-10-01 | Fox Jonathan C |
Director | Award | 728 |
| 2025-08-26 | Russell Alan J |
Director, Chief Scientific Officer | Convert | 100,000 |
| 2025-08-26 | Russell Alan J |
Director, Chief Scientific Officer | Sell | 100,000 |
| 2025-08-26 | Russell Alan J |
Director, Chief Scientific Officer | Convert | 100,000 |
| 2025-08-12 | Russell Alan J |
Director, Chief Scientific Officer | Convert | 5,781 |
| 2025-08-12 | Russell Alan J |
Director, Chief Scientific Officer | Award | 28,125 |
| 2025-08-12 | KOCH KEVIN |
Director, President and CEO | Other | 26,410 |
| 2025-08-12 | Blaustein Robert |
Chief Development Officer | Award | 17,500 |
| 2025-08-12 | Derakhshan Behrad |
Chief Business Officer | Convert | 5,781 |
| 2025-08-12 | Donovan Joanne M. |
CMO | Award | 168,750 |
| 2025-08-12 | Derakhshan Behrad |
Chief Business Officer | Convert | 5,781 |
| 2025-08-12 | KOCH KEVIN |
Director, President and CEO | Convert | 17,968 |
Showing 1–50 of 531 transactions